| Name | Title | Contact Details |
|---|---|---|
Brett Silton |
Head of Corporate Compliance | Profile |
Donna Shiroma |
General Counsel | Profile |
Sebacia is a clinical-stage` private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia’s goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia’s microparticles technology was invented and licensed from Rice University` and the dermatology applications were further developed with researchers from and the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth` Georgia
Synaptive Medical Inc., a Toronto-based medical device and technology company, designs hardware and software that cross traditional barriers in hospitals and improve patient care in and beyond the operating room.
C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.
101Mobility is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.